<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9000850</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2507</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Pediatr.</journal-id>
<journal-title-group>
<journal-title>Current opinion in pediatrics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1040-8703</issn>
<issn pub-type="epub">1531-698X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28719389</article-id>
<article-id pub-id-type="pmc">5653279</article-id>
<article-id pub-id-type="doi">10.1097/MOP.0000000000000530</article-id>
<article-id pub-id-type="manuscript">NIHMS910282</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Contribution to Neurodevelopmental Outcomes in Congenital Heart Disease: Are Some Patients Pre-Determined to Have Developmental Delay?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rollins</surname>
<given-names>Caitlin K.</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Newburger</surname>
<given-names>Jane W.</given-names>
</name>
<degrees>M.D., M.P.H.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>Amy E.</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<aff id="A1">Departments of Neurology (C.K.R.) and Cardiology (J.W.N. and A.E.R.), Boston Children’s Hospital; the Departments of Neurology (C.K.R) and Pediatrics (J.W.N. and A.E.R.), Harvard Medical School</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Correspondence: Amy E. Roberts, Department of Cardiology, Boston Children’s Hospital, 333 Longwood Avenue, Boston, MA 02115; (617) 355-8794; <email>Amy.Roberts@cardio.chboston.org</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p><underline>Conflicts of Interest:</underline> None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>29</volume>
<issue>5</issue>
<fpage>529</fpage>
<lpage>533</lpage>
<!--elocation-id from pubmed: 10.1097/MOP.0000000000000530-->
<abstract>
<sec id="S1">
<title>Purpose of review</title>
<p id="P1">Neurodevelopmental impairment is common in children with moderate to severe congenital heart disease. As children live longer and healthier lives, research has focused on identifying causes of neurodevelopmental morbidity that significantly impact long-term quality of life. This review will address the role of genetic factors in predicting neurodevelopmental outcome in CHD.</p>
</sec>
<sec id="S2">
<title>Recent findings</title>
<p id="P2">A robust literature suggests that among children with various forms of congenital heart disease, those with known genetic/extracardiac anomalies are at highest risk of neurodevelopmental impairment. Advances in genetic technology have identified genetic causes of congenital heart disease in an increasing percentage of patients. Further, emerging data suggest substantial overlap between mutations in children with congenital heart disease and those that have previously been associated with neurodevelopmental disorders.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">Innate and patient factors appear to be more important in predicting neurodevelopmental outcome than medical/surgical variables. Future research is needed to establish a broader understanding of the mutations that contribute to neurodevelopmental disorders and the variations in expressivity and penetrance.</p>
</sec>
</abstract>
<kwd-group>
<kwd>congenital heart disease</kwd>
<kwd>genetics</kwd>
<kwd>brain</kwd>
<kwd>neurodevelopment</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>